News FDA sets June date for Gilead's twice-yearly HIV PrEP Gilead's already dominant position in HIV PrEP could be extended if the FDA approves a new twice-yearly injectable product later this year.
News US federal job cuts reach the FDA, CDC, say reports Recently hired employees of the FDA and CDC look set to be the latest workers affected by sweeping job cuts implemented by the Trump administration.
News RFK Jr-led commission will assess 'threats' to children New HHS Secretary RFK Fr has been given the task of investigating child health in the US, including whether some medicines may pose a threat.
News Kennedy confirmed as HHS Secretary The US Senate today confirmed Robert F Kennedy Jr as Health and Human Services Secretary, after a vote that largely followed party lines.
R&D Defining, building, and implementing the next wave of biopha... In a new podcast, pharmaphorum speaks with two PharmaLex experts about navigating complex R&D processes to unleash the next wave of biopharma.
News FDA starts review of first bronchiectasis drug candidate The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.